{
  "alleleExist":false,
  "dataVersion":"v4.5",
  "diagnosticImplications":[],
  "diagnosticSummary":"",
  "geneExist":true,
  "geneSummary":"PTPRD, a tumor suppressor and receptor protein tyrosine phosphatase, is altered by mutation or deletion in various cancer types including skin and lung cancers.",
  "highestDiagnosticImplicationLevel":null,
  "highestFdaLevel":null,
  "highestPrognosticImplicationLevel":null,
  "highestResistanceLevel":null,
  "highestSensitiveLevel":null,
  "hotspot":false,
  "lastUpdate":"04/23/2018",
  "mutationEffect":{
    "citations":{
      "abstracts":[],
      "pmids":[
        "19478061",
        "25113440"
      ]
    },
    "description":"Truncating mutations in PRPRD can produce serveral C-terminally truncated protein forms, which are likely inactivating. Ectopic expression of tumor-derived PTPRD mutations in cancer cell lines attenuate the tumor suppressive functions of the wildtype protein, resulting in increased cell growth and migration (PMID: 19478061, 25113440).",
    "knownEffect":"Likely Loss-of-function"
  },
  "oncogenic":"Likely Oncogenic",
  "otherSignificantResistanceLevels":[],
  "otherSignificantSensitiveLevels":[],
  "prognosticImplications":[],
  "prognosticSummary":"",
  "query":{
    "alteration":"R179*",
    "alterationType":null,
    "consequence":"stop_gained",
    "entrezGeneId":5789,
    "hgvs":"9:g.8528597G>A",
    "hugoSymbol":"PTPRD",
    "id":null,
    "proteinEnd":179,
    "proteinStart":179,
    "referenceGenome":"GRCh38",
    "svType":null,
    "tumorType":null
  },
  "treatments":[],
  "tumorTypeSummary":"",
  "variantExist":false,
  "variantSummary":"The PTPRD R179* mutation is likely oncogenic.",
  "vus":false
}